Medipost has newly appeared among the top searched stocks.
As of 10:30 AM on the 29th, Medipost is trading at 32,400 KRW, down 0.31% from the previous day. This represents a 22.73% increase compared to September 24. Medipost is known as a stem cell specialized company.
Today, foreigners are tentatively recorded as net buyers of 11,203 shares. Over the past five days, individual investors have been net sellers of 230,530 shares, while foreigners and institutions have been net buyers of 86,616 shares and 148,542 shares, respectively.
On September 28, Medipost was an issue in the market with the headline "Knee Osteoarthritis Stem Cell Treatment Expectations Drive 13% Increase".


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
